tDCS and Cognitive Training for Restrictive Eating Disorders
1 other identifier
interventional
20
1 country
1
Brief Summary
This study looks at adults with restrictive eating disorders who are currently receiving outpatient treatment for their eating disorder to examine whether a new brain stimulation technique called non-invasive transcranial direct current stimulation (tDCS) can enhance brain training. Participation involves interviews, assessments, 10 sessions of brain stimulation (active or sham), and computerized brain training over a 3-4 week period, with one post-intervention visit, and one 1-month follow-up visit.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
Started Aug 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 19, 2024
CompletedStudy Start
First participant enrolled
August 2, 2024
CompletedFirst Posted
Study publicly available on registry
October 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 2, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 2, 2026
August 29, 2025
August 1, 2025
1.8 years
July 19, 2024
August 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
the rate of dropout.
Feasibility and tolerability measure 1. Evaluating for less than 20% dropout over the course of the tDCS for R-EDs study.
14 days average
Number of participants retained in the tDCS
Feasibility and tolerability measure 2 . # of participants retained in the tDCS and cognitive training space of the study (80% or more retention will be used as the assessment threshold).
14 days average
probabilistic reversal learning task
Change from pre intervention to post intervention scores in probabilistic reversal learning task performance
14 days average
Dimensional set shifting task
change from pre to post intervention scores in dimensional set shifting task.
14 days average
Study Arms (2)
Active tDCS
EXPERIMENTAL10 Active tDCS sessions: 10 active sessions of transcranial direct current stimulation paired with cognitive training tasks. Device used is StarStim.
Sham (fake) tDCS
SHAM COMPARATOR10 Sham (fake) tDCS sessions: 10 fake sessions of transcranial direct current stimulation paired with cognitive training tasks. The device will be on the participants head, but the current will not be active.
Interventions
10 active sessions of transcranial direct current stimulation paired with cognitive training tasks. Device used is StarStim.
10 fake sessions of transcranial direct current stimulation paired with cognitive training tasks. The device will be on the participants head, but the current will not be active.
Eligibility Criteria
You may qualify if:
- Age 18-65 years
- Self-reported enrollment in outpatient-level treatment at local eating disorder treatment centers in the Twin Cities region, and meeting DSM-5 criteria for AN (mild severity, based on BMI greater than or equal to 17.0 kg/m2) or atypical AN diagnosis (based on MINI and EDE assessments).
- Participant must be capable of giving informed consent, based on UCSD Brief Assessment of Capacity to Consent (UBACC) risk assessment.
- Sufficient spoken English so as to be able to comprehend testing procedures. Normative ranges on a C-RENAL blood panel (panel and ranges specified here: https://labguide.fairview.org/showtest.asp?testid=3321)
You may not qualify if:
- Substance abuse in the participant
- Neurological condition or other developmental disorder
- Serious psychiatric disorder known to affect brain functioning and cognitive performance (e.g., schizophrenia, schizoaffective disorder)
- Medical instability, which will be evident based on required outpatient treatment status. In standard eating disorders treatment, individuals who are not medically stable are referred to higher levels of care (e.g., residential treatment, inpatient). Therefore, if a participant is enrolled in higher level care for their eating disorder diagnosis, this indicates medical instability and they will be excluded from enrollment in this study.
- tDCS contraindication (e.g., history of craniotomy, history of metallic cranial plates, screws, implanted devices).
- Acute suicidality (suicidalideation with a plan or intent), assessed via MINI suicidality module and Beck Depression Inventory suicide item
- Acute homicidality (homicidal ideation with a plan or intent), assessed via MINI
- Moderate, severe or extreme AN diagnostic severity, based on BMI as per DSM-5 criteria (e.g., BMI \<17.0 kg/m2)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Minnesota
Minneapolis, Minnesota, 55414, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lisa Anderson
University of Minnesota
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- triple blind
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 19, 2024
First Posted
October 2, 2024
Study Start
August 2, 2024
Primary Completion (Estimated)
June 2, 2026
Study Completion (Estimated)
June 2, 2026
Last Updated
August 29, 2025
Record last verified: 2025-08